Biogen (BIIB) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.97 | 0.49 | 2.65 | 1.42 | 1.01 | 0.82 | |||
| Changes by years, y/y, % | -5% | -50% | +444% | -46% | -29% | -0.2% | |||
Biogen. Debt/EBITDA
Biogen. Debt/EBITDA, changes, %
Biogen (BIIB) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | 1.24 | 1.13 | 0.75 | 1.04 | 0.84 | 0.82 | ||
| Changes by years, y/y, % | -47% | -34% | -53% | -23% | -32% | |||
| Changes by quarters, q/q, % | -8% | -9% | -34% | +38% | -19% | |||